Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Role of microRNAs in alcohol-induced liver disorders and non-alcoholic fatty liver disease
Jorge Torres, Ignacio Novo‐Veleiro, Laura Manzanedo, et al.
World Journal of Gastroenterology (2018) Vol. 24, Iss. 36, pp. 4104-4118
Open Access | Times Cited: 103

Showing 1-25 of 103 citing articles:

MicroRNAs in Alzheimer's disease: Potential diagnostic markers and therapeutic targets
Sen Liu, Min Fan, Qiang Zheng, et al.
Biomedicine & Pharmacotherapy (2022) Vol. 148, pp. 112681-112681
Open Access | Times Cited: 124
Alcohol-Related Liver Disease: Basic Mechanisms and Clinical Perspectives
Szu-Yi Liu, I‐Ting Tsai, Yin-Chou Hsu
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 10, pp. 5170-5170
Open Access | Times Cited: 102
Genetic and epigenetic factors determining NAFLD risk
Wenke Jonas, Annette Schürmann
Molecular Metabolism (2020) Vol. 50, pp. 101111-101111
Open Access | Times Cited: 117
Molecular and Functional Roles of MicroRNAs in the Progression of Hepatocellular Carcinoma—A Review
Kyoko Oura, Asahiro Morishita, Tsutomu Masaki
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 21, pp. 8362-8362
Open Access | Times Cited: 112
The Impact of Acute or Chronic Alcohol Intake on the NF-κB Signaling Pathway in Alcohol-Related Liver Disease
Aleksander J. Nowak, Borna Relja
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 24, pp. 9407-9407
Open Access | Times Cited: 71
Diagnosis and Therapeutic Management of Liver Fibrosis by MicroRNA
Tomoko Tadokoro, Asahiro Morishita, Tsutomu Masaki
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 15, pp. 8139-8139
Open Access | Times Cited: 60
Alcohol-Associated Tissue Injury: Current Views on Pathophysiological Mechanisms
Liz Simon, Flavia M. Souza‐Smith, Patricia E. Molina
Annual Review of Physiology (2022) Vol. 84, Iss. 1, pp. 87-112
Open Access | Times Cited: 45
The role of exosomal miRNA in nonalcoholic fatty liver disease
Ali Mahmoudi, Alexandra E. Butler, Tannaz Jamialahmadi, et al.
Journal of Cellular Physiology (2022) Vol. 237, Iss. 4, pp. 2078-2094
Closed Access | Times Cited: 44
Fatty Liver Disease-Alcoholic and Non-Alcoholic: Similar but Different
Stephen Malnick, Pavel Alin, Marina Somin, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 24, pp. 16226-16226
Open Access | Times Cited: 37
What are the common downstream molecular events between alcoholic and nonalcoholic fatty liver?
Giovanni Tarantino, Vincenzo Citro
Lipids in Health and Disease (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 13
Orally Deliverable Sequence-Targeted Fucoxanthin-Loaded Biomimetic Extracellular Vesicles for Alleviation of Nonalcoholic Fatty Liver Disease
Caiyun Wu, Siyuan Xiang, Haitao Wang, et al.
ACS Applied Materials & Interfaces (2024) Vol. 16, Iss. 8, pp. 9854-9867
Closed Access | Times Cited: 13
Extracellular Vesicles as Delivery Vehicles for Non-Coding RNAs: Potential Biomarkers for Chronic Liver Diseases
Arianna Ferro, Gabriele Saccu, Simone Mattivi, et al.
Biomolecules (2024) Vol. 14, Iss. 3, pp. 277-277
Open Access | Times Cited: 13
Noncoding RNAs in Nonalcoholic Fatty Liver Disease: Potential Diagnosis and Prognosis Biomarkers
Olfa Khalifa, Khaoula Errafii‬, Nayla S. Al-Akl, et al.
Disease Markers (2020) Vol. 2020, pp. 1-16
Open Access | Times Cited: 55
Epigenetic contribution to obesity
Meriem Ouni, Annette Schürmann
Mammalian Genome (2020) Vol. 31, Iss. 5-6, pp. 134-145
Open Access | Times Cited: 54
Molecular and Cellular Mediators of the Gut-Liver Axis in the Progression of Liver Diseases
Alix Bruneau, Jana Hundertmark, Adrien Guillot, et al.
Frontiers in Medicine (2021) Vol. 8
Open Access | Times Cited: 53
Quercetin prevents cadmium chloride‐induced hepatic steatosis and fibrosis by downregulating the transcription of miR‐21
Ghedeir M. Alshammari, Wahidah H. Al‐Qahtani, Nora A. AlFaris, et al.
BioFactors (2021) Vol. 47, Iss. 3, pp. 489-505
Closed Access | Times Cited: 42
MicroRNA-122-5p Inhibition Improves Inflammation and Oxidative Stress Damage in Dietary-Induced Non-alcoholic Fatty Liver Disease Through Targeting FOXO3
Yiyi Hu, Xuetao Peng, Guoping Du, et al.
Frontiers in Physiology (2022) Vol. 13
Open Access | Times Cited: 33
Alcohol and the mechanisms of liver disease
Mo Chen, Wanglei Zhong, Weiqi Xu
Journal of Gastroenterology and Hepatology (2023) Vol. 38, Iss. 8, pp. 1233-1240
Open Access | Times Cited: 20
Extracellular vesicle therapy for obesity-induced NAFLD: a comprehensive review of current evidence
Jiali Zhang, Baochen Ma, Zixu Wang, et al.
Cell Communication and Signaling (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 6
Comprehensive profiling of serum microRNAs in normal and non-alcoholic fatty liver disease (NAFLD) patients
Jianwei Zhang, Abdullah Khan, Nauman Rahim Khan, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access
Bioengineered extracellular vesicles: The path to precision medicine in liver diseases
Ashmit Mittal, Vibhuti R. Jakhmola, Sukriti Baweja
Liver Research (2025)
Open Access
miR-125b promotes the NF-κB-mediated inflammatory response in NAFLD via directly targeting TNFAIP3
Qian Zhang, Kun Yu, Yazhen Cao, et al.
Life Sciences (2021) Vol. 270, pp. 119071-119071
Closed Access | Times Cited: 35
Cr (VI) induces abnormalities in glucose and lipid metabolism through ROS/Nrf2 signaling
Xiaohong Li, Shengwen He, Jian Zhou, et al.
Ecotoxicology and Environmental Safety (2021) Vol. 219, pp. 112320-112320
Open Access | Times Cited: 34
Epigenetics of alcohol-related liver diseases
Nawras W. Habash, Tejasav S. Sehrawat, Vijay H. Shah, et al.
JHEP Reports (2022) Vol. 4, Iss. 5, pp. 100466-100466
Open Access | Times Cited: 25
A crosstalk between epigenetic modulations and non-alcoholic fatty liver disease progression
Meysam Ramezani, Mahsa Zobeiry, Shahrokh Abdolahi, et al.
Pathology - Research and Practice (2023) Vol. 251, pp. 154809-154809
Closed Access | Times Cited: 13
Page 1 - Next Page

Scroll to top